Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05024552
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2021-08-23
Brief Title:
Vyxeos Plus Gilteritinib in Relapsed or Refractory FLT3-Mutated AML
Sponsor:
Organization:
H Lee Moffitt Cancer Center and Research Institute